Patents
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
07/2013
07/23/2013US8492542 Method for producing bicyclic guanidines by use of a cyclic thiourea
07/23/2013US8492393 Heterobicyclic carboxamides as inhibitors for kinases
07/23/2013US8492389 Inhibitors of human phosphatidylinositol 3-kinase delta
07/23/2013US8492376 Heteroaryl-cyclohexyl-tetraazabenzo[e]azulenes
07/23/2013US8492374 Azaazulene compounds
07/18/2013WO2013106792A1 Heterocyclic compounds and uses as anticancer agents.
07/18/2013WO2013106728A1 Agents that prevent or repair skin damage
07/18/2013WO2013106614A1 Triazolyl-substituted pyridyl compounds useful as kinase inhibitors
07/18/2013WO2013106612A1 Heterocyclic-substituted pyridyl compounds useful as kinase inhibitors
07/18/2013WO2013105057A1 Fused pyrroles as ip receptor agonists for the treatment of pulmonary arterial hypertension (pah) and related disorders
07/18/2013WO2013104830A1 Novel heteroarylamide derivatives having antiandrogenic properties
07/18/2013WO2013104611A1 Substituted pyrazolopyrimidines as akt kinase inhibitors
07/18/2013WO2013104610A1 Substituted imidazopyrazines as akt kinase inhibitors
07/18/2013WO2013104598A2 Substituted, annulated imidazoles and pyrazoles, and use thereof
07/18/2013US20130184307 Substituted tricyclic acid derivatives as s1p1 receptor agonists useful in the treatment of autoimmune and inflammatory disorders
07/18/2013US20130184285 Pyrrolopyrimidine compounds and their uses
07/18/2013US20130184282 Ip receptor agonist heterocyclic compounds
07/18/2013US20130184274 Protein Kinase Inhibitors and Methods of Treatment
07/18/2013US20130184273 Bicyclic pyrimidines
07/18/2013US20130184271 Methods for Treating Parkinson's Disease Using Pro-Neurogenic Compounds
07/18/2013US20130184259 Pyridones useful as inhibitors of kinases
07/18/2013US20130184256 New substituted glycinamides, process for their manufacture and use thereof as medicaments
07/18/2013US20130184240 Hetero ring-fused imidazole derivative having ampk activating effect
07/18/2013US20130180589 Organic photovoltaic cell materials and components
07/18/2013CA2860847A1 Substituted, annulated imidazoles and pyrazoles, and use thereof
07/17/2013EP2615096A1 Quinoxaline compound
07/17/2013EP2615091A2 Solid forms comprising 4-[9-(3S)-(tetrahydro-furan-3-yl)-8-(2,4,6-trifluoro-phenylamino)-9H-purin-2-ylamino]-trans-cyclohexan-1-ol, compositions thereof, and uses therewith
07/17/2013EP2615090A1 Nitrogen-containing fused heterocyclic compounds and their use as beta amyloid production inhibitors
07/17/2013EP2615088A1 Composition, synthesis and use of new substituted pyran and pterin compounds
07/17/2013EP2615087A2 Phenylalanine derivatives
07/17/2013EP2614684A1 Broadly absorbing metalloporphyrin-based multichromophoric arrays for triplet harvesting
07/17/2013EP2614067A2 Conductive open frameworks
07/17/2013EP2614065A1 Substituted pyrazolo-quinazoline derivatives as kinase inhibitors
07/17/2013EP2614064A1 Inhibitors of human immunodeficiency virus replication
07/17/2013EP2614063A1 Substituted imidazopyridazines
07/17/2013EP2614062A1 Imidazo [1, 2]pyridazin compounds and compositions as trk inhibitors
07/17/2013CN1771298B Fluorescent diketopyrrolopyrroles
07/17/2013CN1660033B Composition for dyeing keratinous fibers comprising at least one diamino-n,n-dihydropyrazolone derivative
07/17/2013CN103209982A Novel compound of a reverse-turn mimetic and a production method and use therefor
07/17/2013CN103209963A 2-quinolinyl-acetic acid derivatives as HIV antiviral compounds
07/17/2013CN103204858A Novel chirality antianxiety medicine prepared on basis of tartaric acid resolution and composition technique
07/17/2013CN103204857A Synthesis method of 4-chlorine-2-(methylmercapto)-7H-pyrrolo [2, 3-D] pyrimidine
07/17/2013CN103204856A Deuterated alprazolam and preparation method thereof
07/17/2013CN103204855A Compound I tetrazole (1, 5-a) pyrimidine-5, 7-diol and synthetic route thereof
07/17/2013CN103204854A Tetranitroglycoluril preparation method
07/17/2013CN103204851A Benzamide derivative containing fused heterocyclic group and therapeutic use thereof
07/17/2013CN103204846A Carbazole derivative, organic electroluminescent device thereof, and manufacturing method of device
07/17/2013CN103204815A 4-(4-cyano-2-thioaryl)dihydropyrimidinones And Use Thereof
07/17/2013CN102659815B Method for preparing selective anticoagulant ticagrelor and intermediates thereof
07/17/2013CN102295647B All-alkyl substituted triindenyl cyclopi trimeric-indole derivative and preparation method thereof
07/17/2013CN102153606B Nucleoside derivatives as well as stereo isomers, pharmaceutically acceptable salts and application thereof
07/17/2013CN101553489B 4-amino-3-arylamino-6-arylpyrazolo[3,4-d]pyrimidine derivatives, methods for their preparation and their use as antiviral agents
07/17/2013CN101434605B Heterocyclic compound and an organic light emitting device comprising the same
07/17/2013CN101248050B Organic compounds
07/17/2013CN101203495B Benzocycloheptapyridines as inhibitors of the receptor tyrosine kinase MET
07/16/2013US8487099 Gamma secretase modulators
07/16/2013US8487098 Synergistic combination of flumetsulam or diclosulam with isothiazolones
07/16/2013US8487096 Imidazo[1,2-B][1,2,4]triazines as C-MET inhibitors
07/16/2013US8486989 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
07/16/2013US8486979 Analgesics; central nervous system disorders; attentiondeficit disorders;cognition activators; bipolar disorders; Alzheimer's disease; Down's syndrome; brain disorders
07/16/2013US8486954 Heterobicyclic carboxamides as inhibitors for kinases
07/16/2013US8486945 Heterocyclic inhibitors of an Hh-signal cascade, medicinal compositions based thereon and methods for treating diseases caused by the aberrant activity of an Hh-signal system
07/16/2013US8486938 Pyrazolo[1,5-a]pyrimidines for antiviral treatment
07/16/2013US8486928 Super-oxide dismutase mimetics
07/16/2013US8486902 Hydroxyl, keto, and glucuronide derivatives of 3-(4-(7H-pyrrolo[2,3-d] pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile
07/11/2013WO2013102929A1 Novel compounds for treatment of diabetes, obesity or related disorders
07/11/2013WO2013102242A1 Heterocyclic compounds and methods for their use
07/11/2013WO2013066458A3 Fluorescent sensing of vapors using tubular nanofibril materials
07/11/2013WO2013049352A3 Anti-viral compounds
07/11/2013WO2013039785A3 Heterocyclic inhibitors of histamine receptors for the treatment of disease
07/11/2013WO2012174379A3 Polyhedral cage-containing metalloporphyrin frameworks, methods of making, and methods of using
07/11/2013US20130178623 4-amino-3-(imidazolyl)-pyrazolo[3,4-d]pyrimidines
07/11/2013US20130178622 Methods and Compositions for Treating Cancer
07/11/2013US20130178618 Novel pharmaceutical intermediates and methods for preparing the same
07/11/2013US20130178500 HEXAHYDROPYRROLO[3,4-b]PYRROLE DERIVATIVES, PREPARATION METHODS AND PHARMACEUTICAL USES THEREOF
07/11/2013US20130178486 Serine/threonine kinase inhibitors
07/11/2013US20130178483 Methods and Compositions for Inhibition of Bone Resorption
07/11/2013US20130178461 Inhibitors of bruton's tyrosine kinase
07/11/2013US20130178458 Substituted (1-(methylsulfonyl)azetidin-3-yl)(heterocycloalkyl)methanone analogs as antagonists of muscarinic acetylcholine m1 receptors
07/11/2013DE102012200357A1 New fluoroalkyl-substituted pyrazolopyridine compounds are soluble guanylate cyclase stimulators, useful to treat e.g. heart disease, angina pectoris, hypertension, pulmonary hypertension, ischemia, vascular disease or renal insufficiency
07/11/2013DE102012200356A1 New substituted imidazopyrid(az)ine compounds are soluble guanylate cyclase stimulators, useful to treat e.g. heart disease, angina pectoris, hypertension, pulmonary hypertension, ischemia, vascular disease or renal insufficiency
07/11/2013DE102012200352A1 Substituierte, annellierte Imidazole und Pyrazole und ihre Verwendung Substituted fused imidazoles and pyrazoles and their use
07/11/2013DE102012200351A1 New substituted annellated pyrimidine compounds are guanylate cyclase stimulators useful to treat and/or prevent heart failure, hypertension, ischemia, vascular disease, renal failure, thromboembolic disorders and fibrotic diseases
07/10/2013EP2612862A2 Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
07/10/2013EP2612860A1 Quinazoline derivatives substituted by aniline, preparation method and use thereof
07/10/2013EP2611810A1 Substituted tetrahydropyrrolopyrazine derivatives
07/10/2013EP2611809A1 Azolopyridine and azolopyrimidine compounds and methods of use thereof
07/10/2013EP2611808A1 Pyrazolopyridinone derivatives as lpa receptor antagonists
07/10/2013EP2611802A1 Bicyclic aza heterocycles, and use thereof
07/10/2013EP2611798A1 Pyridazinones, method of making, and method of use thereof
07/10/2013EP2611790A1 Pyridinones/pyrazinones, method of making, and method of use thereof
07/10/2013CN103201277A Pyridazinones, method of making, and method of use thereof
07/10/2013CN103201274A Pyrrolidine derivatives used as cathepsin inhibitors
07/10/2013CN103193786A Water-soluble fullerene-tetra(p-hydroxy phenyl) porphyrin as well as preparation method and application thereof
07/10/2013CN103193785A Graphene-like C3N4 material, as well as preparation method and use thereof
07/10/2013CN103193784A Pyrimidine group-containing rigid conjugated macrocyclic compound, as well as preparation method and application thereof
07/10/2013CN103193783A Method for preparing hemin from yak blood powder as raw material
07/10/2013CN103193782A Photosensitizer sodium chlorophyllin derivatives and their preparation method and use
07/10/2013CN103193781A Specific inhibition compound of SAHN enzyme protein and synthetic method of specific inhibition compound
07/10/2013CN103193780A Use of 4,7-dihydrotetrazyl[1,5-alpha]pyrimidine compound and its derivatives in preparation of drug for prevention or treatment on cerebral hemorrhage
1 ... 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 ... 573